Cogent Biosciences, Inc.
COGT
$37.93
$0.621.66%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -31.11% | -35.24% | -50.89% | -14.58% | -24.73% |
| Total Depreciation and Amortization | 18.32% | 1.49% | 2.98% | 4.56% | 7.13% |
| Total Amortization of Deferred Charges | 350.79% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 62.56% | 75.22% | 196.70% | 151.01% | -21.13% |
| Change in Net Operating Assets | -82.95% | -44.76% | 111.67% | -64.46% | 204.15% |
| Cash from Operations | -41.67% | -30.63% | -30.59% | -23.66% | -27.73% |
| Capital Expenditure | -182.44% | 17.92% | -981.33% | 76.79% | 11.49% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 62.04% | -151.49% | -621.42% | -356.31% | 110.70% |
| Cash from Investing | 60.27% | -152.55% | -623.37% | -357.61% | 110.53% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 517.73% | 110.40% | -- | 37,063.78% | -93.79% |
| Repurchase of Common Stock | -- | -- | -322.46% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 49.44% | -- | -319.98% | -- | 76.13% |
| Cash from Financing | -93.74% | 110.40% | 2,264,011.54% | 34,734.46% | 18,548.05% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3,864.01% | -354.34% | 16,578.13% | -122.26% | 101.25% |